ScienTec Consulting's Singapore Biomedical HR Trends Report 2013
•
1 like•549 views
ScienTec Consulting presents key figures and issues affecting Singapore's biomedical industry talent needs.
Recommended
Recommended
More Related Content
Similar to ScienTec Consulting's Singapore Biomedical HR Trends Report 2013
Similar to ScienTec Consulting's Singapore Biomedical HR Trends Report 2013 (20)
Recently uploaded
Recently uploaded (20)
ScienTec Consulting's Singapore Biomedical HR Trends Report 2013
- 2. “... vision for Singapore ... to be the Biopolis of Asia, an international Biomedical Sciences cluster advancing human health through the pursuit of excellence in R&D, manufacturingpursuit of excellence in R&D, manufacturing and healthcare delivery.” SINGAPORE ECONOMIC DEVELOPMENT BOARD
- 3. SINGAPORE IS 3rd MOST BIOTECH INNOVATIVE COUNTRY “Singapore has a score of 35.57 and only the US (38) and Denmarkand only the US (38) and Denmark (37.18) are ahead ...” SCIENTIFIC AMERICAN WORLDVIEW 2012 Scientific American Worldview Scorecard – An assessment tool for countries to review, in an objective manner, its biotechnology-innovation performance and the behaviours that generated that result.
- 4. SINGAPORE IS 5th MOST COMPETITIVE IN THE WORLD “Very stable and enduring competitiveness model that relies oncompetitiveness model that relies on long-term advantages such as technology, education and advanced infrastructure.” INTERNATIONAL INSTITUTE OF MANAGEMENT DEVELOPMENT WORLD COMPETITIVE RANKINGS 2013
- 6. Growth % 2011 2012 Manufacturing 7.7% 2.2% Construction 6.3% 8.2% Wholesale & Retail Trade 1.6% -0.7% Transportation & Storage 3.8% 2.7%Transportation & Storage 3.8% 2.7% accommodation & Food Services 8.2% 2.8% Information & Communications 3.6% 2.6% Finance & Insurance 8.9% 0.5% Business Services 3.0% 3.9% MINISTRY OF TRADE AND INDUSTRY
- 7. “Manufacturing continues to remain a key pillar of Singapore's economy. It accounts for about 21% of our gross domestic product (GDP), and we are ……….……….………. product (GDP), and we are committed to sustaining it at 20% to 25% of GDP.” MINISTRY OF TRADE AND INDUSTRY, 2013
- 8. 20.0% 25.0% 30.0% 35.0% 2011 2012 MANUFACTURING CLUSTER GROWTH % 0.0% 5.0% 10.0% 15.0% 20.0% Computer, Electronic & Optical Products Petroleum Products Chemicals & Chemical Products Machinery & Equipment Pharmaceutical Products Transport Equipment except Motor Vehicles Fabricated Metal Products MINISTRY OF TRADE AND INDUSTRY
- 9. 12% 9% 15.0% 20.0% 25.0% 2011 2012 Change MANUFACTURING CLUSTER GROWTH % 1% 1% 9% 0.0% 5.0% 10.0% Petroleum Products Chemicals & Chemical Products Machinery & Equipment Pharmaceutical Products MINISTRY OF TRADE AND INDUSTRY
- 10. 2000 2011 BMS Manufacturing Output $6.3 Billion $27 Billion % Share Of Total Singapore Manufacturing Output 4% 10% BIOMEDICAL SCIENCE HIGHLIGHTS BMS R&D Business Expenditure $47 Million $574 Million BMS Manufacturing Employment 6,000 15,000 BMS R&D Employment 2,200 7,000 MINISTRY OF TRADE AND INDUSTRY
- 11. 8PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 30MEDICAL TECHNOLOGY COMPANIESMEDICAL TECHNOLOGY COMPANIES 50MANUFACTURING FACILITIES EDB, 2013 ……….……….……….
- 12. 8PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES Of the top 10 are in Singapore. Novartis Roche/Genentech GSK Pfizer Abbott Abbvie Merck Sanofi J&J ……….……….………. EDB, 2013
- 13. 30MEDICAL TECHNOLOGY COMPANIES OF WHICH Those who have Manufacturing, R&D and RHQ functions in Singapore include: EDB, 2013 AB SCIEX Baxter International Becton Dickinson BIOTRONIK Hoya Surgical Optics Life Technologies Medtronic Siemens Medical Instruments. ……….……….……….
- 14. 30MEDICAL TECHNOLOGY COMPANIES IN SINGAPORE PRODUCE 10% of the world’s contact lenses 50% of the world’s thermal cyclers and mass spectrometers 70% of the world’s microarrays 3M AB SCIEX Affymetrix Agilent Alcon Argon Medical Baxter BD Bio-Rad Biosensors Clearlab Creganna Tactx Edwards Emerald Medical Fluidigm Hoya Illumina Life Technologies Medtronic Menicon MPBiomedicals PerkinElmer ResMed Siemens Sirtex Sysmex Thermo Fisher Scientific TriReme Medical Quattro Vascular Vela Diagnostics West Pharma ……….……….………. EDB, 2013
- 15. 30MEDICAL TECHNOLOGY COMPANIES HAVE COLLECTIVELY Doubledthe manpower base ……….……….………. EDB, 2013
- 16. “Singapore has committed S$16.1 billion in continued support of research, innovation and enterprise activities between 2011 and 2015.” “Out of the S$16.1 billion, S$3.7 billion is ……….……….………. S$3.7 billion is dedicated to enhancing existing biomedical R&D infrastructure, integrating multi-disciplinary research and translating basic science into tangible outcomes. ” EDB, 2013
- 17. PHASE 1 (2000-2005): BUILDING THE FOUNDATION PHASE 2 (2006-2010): SINGAPORE BIOMEDICAL INDUSTRY PLAN PHASE 2 (2006-2010): STRENGTHENING TRANSLATIONAL AND CLINICAL RESEARCH CAPABILITIES PHASE 3 (2011-2015): CAPTURING OPPORTUNITIES FOR GREATER ECONOMIC AND HEALTH IMPACT MINISTRY OF TRADE AND INDUSTRY
- 18. WHY SINGAPORE?
- 19. ESTABLISHED KEY INFRASTRUCTURE AND CAPABILITIES SINGAPORE Research institutes and consortia in clinical sciences, genomics, bioengineering, molecular/cell biology, medical biology, bio-imaging and immunology. Dedicated facilities for biomedical science R&D doing drug discovery, translational and clinical research. State-of-the-art infrastructure available at Biopolis and Tuas Biomedical Park.
- 20. PUBLIC-PRIVATE PARTNERSHIP A network of 30 public-sector research institutes, academic medical centres, medical institutes and hospitals are open to partnering with SINGAPORE centres, medical institutes and hospitals are open to partnering with companies to address unmet healthcare needs. Leading companies such as AstraZeneca, Bayer, GlaxoSmithKline and Lilly are collaborating with Singapore partners across drug discovery and development activities.
- 22. 1.5% 2.0% 2.5% UNEMPLOYMENT RATE (SEASONALLY ADJUSTED) 2.1% 2.0% 0.0% 0.5% 1.0% 2011 2012 MINISTRY OF MANPOWER
- 23. 50% 60% 70% 80% 90% 100% Others Cleaners, Labourers & Related Workers Plant & Machine Operators & Assemblers Production Craftsmen & Related Workers EMPLOYMENT COMPOSITION 0% 10% 20% 30% 40% 50% 2006 2007 2008 2009 2010 2011 Workers Service & Sales Workers Clerical Workers Technicians & Associate Professionals Professionals MINISTRY OF MANPOWER
- 24. LIFE SCIENCE VACANCIES 4% 6% 8% 10% 12% 14% 16% Job Boards 0% 2% 4%
- 25. HOT JOBS RESEARCH & DEVELOPMENT • HODs • Regional Clinical Operations Managers • Clinical Specialists/Clinicians • Regional Clinical Research • Researchers• Researchers • Forensic Author • Chemists/Microbiologist • Product Development/Prototyping • Scientists • Regulatory, CMC, Quality and Medical Affairs • Senior/Engineers • PV, Study Specialist/Managers • Project Managers
- 26. HOT JOBS SALES & MARKETING • Regional/Product Managers • Commercial Managers • Marketing Managers • Product Specialists/Executives • Account Managers• Account Managers • Sales Managers/Executives • Regional Consultants BUSINESS & ADMINISTRATIVE SUPPORT • Corporate Planning • Administrative Support • Procurement/Purchasing • Logistics/Supply Chain • Finance/FP&A/Controlling
- 27. HOT JOBS ENGINEERING • System • Electrical/Electronics • Mechatronics • Software/Firmware • Mechanical• Mechanical • Maintenance/Utilities • Process/Manufacturing OPERATIONS • Facility Manager/Supervisors • Production/Manufacturing/Plant Manager • Planner/Buyer
- 28. DEMAND & SUPPLY
- 29. 7,000 RSEs(RESEARCH SCIENTISTS AND ENGINEERS) 3,000 PhDs3,000 PhDs EDB, 2011
- 32. CHALLENGESTALENT Fishing in the same pool.Fishing in the same pool.
- 33. CHALLENGESTALENT Lack international experience.Lack international experience.
- 36. LOCAL RETURNING EXPATRIATE SOURCES TALENT There is a growing base of academically qualified talents for entry-level or commercial roles. May lack MNC background. Experienced talents will have inflated salary expectations. $$$$
- 37. LOCAL RETURNING EXPATRIATE SOURCES TALENT Understanding of Western strategic paradigms, and a perspective on home-market application. Still need to be reintegrated into local culture. May not necessarily be locally connected.
- 38. LOCAL RETURNING EXPATRIATE SOURCES TALENT Understanding of MNC standards, breadth of expertise and global relationships that can be leveraged. Cultural barriers can lead to challenging engagements. Expat packages are costly and complex to setup.
- 40. 1 Process Design 2 Employer Branding (Pull Factors) 8 Transition & Retention 7 Offer Strategy 3 Job Scope (Pull Factors) 4 Requirement Alignment 5 Target & Attract (Pull & Push) (Pull Factors) 6 Competency Fit & Risk Assessment ....... ....... ....
- 41. We offer meaningful attention and a long-term relationship for clients, candidates and associates. Our collaborative approach underpins all our activities to ensure a pragmatic approach to your needs, with commitment to excellence.